D'Orazio & Associates, Inc. Viatris Inc Transaction History
D'Orazio & Associates, Inc.
- $619 Million
- Q1 2024
A detailed history of D'Orazio & Associates, Inc. transactions in Viatris Inc stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 13,810 shares of VTRS stock, worth $149,148. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,810
Previous 13,472
2.51%
Holding current value
$149,148
Previous $145,000
13.1%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding VTRS
# of Institutions
1,103Shares Held
945MCall Options Held
3.49MPut Options Held
2.6M-
Vanguard Group Inc Valley Forge, PA142MShares$1.53 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY93.3MShares$1.01 Billion0.03% of portfolio
-
State Street Corp Boston, MA62.8MShares$678 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD57.9MShares$625 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$621 Million3.85% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...